Novocure Stock Based Compensation from 2010 to 2025

NVCR Stock

USD 21.55 0.55 2.62%

Novocure Stock Based Compensation yearly trend continues to be relatively stable with very little volatility. Stock Based Compensation is likely to grow to about 139.6 M this year. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2014-09-30

Previous Quarter

31.8 M

Current Value

31.4 M

Quarterly Volatility

10.8 M

Yuan Drop

Covid

Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.8 M, Interest Expense of 7.6 M or Selling General Administrative of 198.1 M, as well as many indicators such as Price To Sales Ratio of 3.41, Dividend Yield of 0.0 or PTB Ratio of 3.75. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.

Check out the analysis of Novocure Correlation against competitors.

To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Latest Novocure's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Novocure over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Novocure's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Novocure Stock Based Compensation Regression Statistics

	Arithmetic Mean	52,763,179
	Geometric Mean	26,960,499
	Coefficient Of Variation	95.38
	Mean Deviation	43,643,848
	Median	39,846,000
	Standard Deviation	50,326,390
	Sample Variance	2532.7T
	Range	135M
	R-Value	0.96
	Mean Square Error	238T
	R-Squared	0.91
	Slope	10,096,486
	Total Sum of Squares	37991.2T

Novocure Stock Based Compensation History

	2025	139.6 M
	2024	132.9 M
	2023	115.6 M
	2022	107 M
	2021	94.9 M
	2020	75.7 M
	2019	52.4 M

Other Fundumenentals of Novocure

Stock Based Compensation To Revenue

Novocure Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Property Plant Equipment	Long Term Investments	Current Deferred Revenue	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital
Total Assets		0.87	0.88	0.96	-0.86	0.98	0.99	0.84	0.99	0.99	0.73	0.93	0.52	0.72	0.75	0.93	0.99	0.94	0.96	0.96
Total Stockholder Equity	0.87		0.98	0.79	-0.62	0.77	0.82	0.82	0.88	0.81	0.51	0.94	0.31	0.62	0.62	0.88	0.84	0.89	0.94	0.94
Net Tangible Assets	0.88	0.98		0.8	-0.66	0.8	0.84	0.8	0.88	0.83	0.52	0.96	0.37	0.64	0.65	0.88	0.85	0.93	0.95	0.95
Net Debt	0.96	0.79	0.8		-0.9	0.95	0.98	0.85	0.98	0.98	0.79	0.91	0.66	0.77	0.79	0.91	0.96	0.92	0.93	0.93
Retained Earnings	-0.86	-0.62	-0.66	-0.9		-0.89	-0.89	-0.82	-0.85	-0.9	-0.92	-0.79	-0.75	-0.76	-0.9	-0.85	-0.83	-0.83	-0.79	-0.78
Accounts Payable	0.98	0.77	0.8	0.95	-0.89		0.98	0.78	0.95	0.99	0.72	0.87	0.58	0.72	0.74	0.88	0.98	0.92	0.91	0.9
Long Term Debt	0.99	0.82	0.84	0.98	-0.89	0.98		0.84	0.98	1.0	0.76	0.92	0.58	0.75	0.77	0.93	0.99	0.93	0.95	0.95
Net Receivables	0.84	0.82	0.8	0.85	-0.82	0.78	0.84		0.84	0.84	0.81	0.9	0.52	0.83	0.88	0.97	0.79	0.87	0.88	0.89
Short Term Investments	0.99	0.88	0.88	0.98	-0.85	0.95	0.98	0.84		0.98	0.71	0.93	0.54	0.73	0.74	0.92	0.98	0.93	0.96	0.96
Total Liab	0.99	0.81	0.83	0.98	-0.9	0.99	1.0	0.84	0.98		0.77	0.91	0.59	0.75	0.78	0.93	0.99	0.94	0.94	0.94
Short Long Term Debt	0.73	0.51	0.52	0.79	-0.92	0.72	0.76	0.81	0.71	0.77		0.68	0.79	0.73	0.93	0.77	0.67	0.69	0.65	0.66
Total Current Assets	0.93	0.94	0.96	0.91	-0.79	0.87	0.92	0.9	0.93	0.91	0.68		0.53	0.77	0.78	0.96	0.91	0.97	0.99	0.99
Short Term Debt	0.52	0.31	0.37	0.66	-0.75	0.58	0.58	0.52	0.54	0.59	0.79	0.53		0.71	0.72	0.49	0.51	0.54	0.48	0.47
Property Plant Equipment	0.72	0.62	0.64	0.77	-0.76	0.72	0.75	0.83	0.73	0.75	0.73	0.77	0.71		0.78	0.78	0.71	0.74	0.74	0.73
Long Term Investments	0.75	0.62	0.65	0.79	-0.9	0.74	0.77	0.88	0.74	0.78	0.93	0.78	0.72	0.78		0.86	0.69	0.79	0.73	0.74
Current Deferred Revenue	0.93	0.88	0.88	0.91	-0.85	0.88	0.93	0.97	0.92	0.93	0.77	0.96	0.49	0.78	0.86		0.9	0.96	0.96	0.96
Long Term Debt Total	0.99	0.84	0.85	0.96	-0.83	0.98	0.99	0.79	0.98	0.99	0.67	0.91	0.51	0.71	0.69	0.9		0.93	0.95	0.95
Capital Surpluse	0.94	0.89	0.93	0.92	-0.83	0.92	0.93	0.87	0.93	0.94	0.69	0.97	0.54	0.74	0.79	0.96	0.93		0.98	0.97
Net Invested Capital	0.96	0.94	0.95	0.93	-0.79	0.91	0.95	0.88	0.96	0.94	0.65	0.99	0.48	0.74	0.73	0.96	0.95	0.98		1.0
Net Working Capital	0.96	0.94	0.95	0.93	-0.78	0.9	0.95	0.89	0.96	0.94	0.66	0.99	0.47	0.73	0.74	0.96	0.95	0.97	1.0

Click cells to compare fundamentals

About Novocure Financial Statements

Novocure shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Novocure investors may analyze each financial statement separately, they are all interrelated. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novocure's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Stock Based Compensation	132.9 M	139.6 M
Stock Based Compensation To Revenue	0.23	0.26

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Novocure Stock Based Compensation from 2010 to 2025

Latest Novocure's Stock Based Compensation Growth Pattern

Novocure Stock Based Compensation Regression Statistics

Novocure Stock Based Compensation History

Other Fundumenentals of Novocure

Novocure Stock Based Compensation component correlations

About Novocure Financial Statements

Additional Tools for Novocure Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY